If it's a cap raise, you may have your chance. But I reckon it will be a slim window, if any, before the price continues to surge.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025